Effect of napabucasin and doxorubicin via the Jak2/Stat3 signaling pathway in suppressing the proliferation of neuroblastoma cells
Acta Cirúrgica Brasileira · 2024
DOI: 10.1590/acb396624 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Cirúrgica Brasileira, 2024. Verfasst von İlker Ünlü und 2 weiteren Autor:innen. Beteiligte Einrichtung: Beykent University - Faculty of Medicine - Department of Brain Surgery - Istanbul - Turkey. Hauptthemen laut MEDLINE: Janus Kinase 2, STAT3 Transcription Factor, Cell Proliferation, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Napabucasin (NP) is a natural compound that can suppress cancer cell proliferation and cell cycle by inhibition of the signal transducer and activator of transcription 3 (STAT3) gene. We examined the effects of NP on the proliferation and invasion of neuroblastoma cells (SH-SY5Y).
Methods
Human neuroblastoma SH-SY5Y cell line was used in this study. NP was administered to groups at the doses of 0.3–1 µM. Cell viability was analyzed by MTT assay. Real-time quantitative reverse transcription polymerase chain reaction and western blot analysis assessed the expressions of interleukin (IL)-6 dependent Jak2/Stat3 signaling pathway. The MTT cell viability method was applied to determine the antagonistic-synergistic effects and inhibitory concentration (IC50) doses of doxorubicin (DX) and NP.
Results
It was determined that 0.3–1 µM doses of NP killed the cells almost completely after 48 hours, and also that Jak2/Stat3 expressions decreased dose-dependently via IL-6. At the protein level, NP and DX were found to reduce Jak2 and Stat3 levels.
Conclusions
NP showed that it suppresses the proliferation of neuroblastoma cells. Due to its inhibitory effect on Jak2 and Stat3, it can be used to prevent invasion of SH-SY5Y cells. NP, which can inactivate Jak2/Stat3, can be used as a treatment agent by combining with DX in proliferation pathway in neuroblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Beykent University - Faculty of Medicine - Department of Brain Surgery - Istanbul - Turkey.
- Dicle University - Faculty of Medicine - Department of Anatomy - Diyarbakir - Turkey.
- Atatürk University - Department of Gynecology and Obstetrics - Faculty of Medicine - Erzurum - Turkey.
Zitieren
APA
Ünlü, İ., Tuncer, M. C., & Özdemir, İ. (2024). Effect of napabucasin and doxorubicin via the Jak2/Stat3 signaling pathway in suppressing the proliferation of neuroblastoma cells. Acta Cirúrgica Brasileira. https://doi.org/10.1590/acb396624
Vancouver
Ünlü İ, Tuncer MC, Özdemir İ. Effect of napabucasin and doxorubicin via the Jak2/Stat3 signaling pathway in suppressing the proliferation of neuroblastoma cells. Acta Cirúrgica Brasileira. 2024. doi:10.1590/acb396624
BibTeX
@article{nl2024,
author = {Ünlü, İlker and Tuncer, Mehmet Cudi and Özdemir, İlhan},
title = {Effect of napabucasin and doxorubicin via the Jak2/Stat3 signaling pathway in suppressing the proliferation of neuroblastoma cells},
journal = {Acta Cirúrgica Brasileira},
year = {2024},
doi = {10.1590/acb396624}
}
EUVIMED